Drugs / Inactivated Poliomyelitis Vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT07688369 Comparator | Jul → Nov 2026 expected | poliomyelitis | Serum Institute of India Pvt. Ltd. | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Inactivated Poliomyelitis Vaccine | “Inactivated Poliomyelitis Vaccine (IPOL)” NCT07688369 ↗ |
| Known as | IPOL | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07688369 ↗ |
| Modality | Vaccine | “IPOL (inactivated poliovirus vaccine) is a marketed Sanofi” NCT07688369 ↗ |